AgeX Therapeutics, Inc. carries a market capitalization of 27.76M, placing it among publicly traded companies globally.
| Market Cap | 27.76M |
| Enterprise Value | N/A |
AgeX Therapeutics, Inc.'s stock has declined approximately -51.82292% over the past 52 weeks. The 50-day moving average sits at 13.98, while the 200-day moving average is 19.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | -51.82292% |
| 50-Day Moving Average | 13.98 |
| 200-Day Moving Average | 19.89 |
| Average Volume (20 Days) | N/A |
AgeX Therapeutics, Inc.'s most recent stock split took place on March 15, 2024 with a 3517:100 split ratio.
| Last Split Date | 3/15/2024 |
| Split Ratio | 3517:100 |